Carrying a firearm in the Garden State is coming with some real growing pains for some people. That’s understandable – somewhat. Something that was completely verboten and looked down upon as be.
Is it ultimately whether a judge can make a decision that supersedes the authority of the fda? you know, jim, i think that s what s lurking in the background. but jennifer s right that the real question before the justices this week is the harm question when a party goes to the supreme court and asks for what we call emergency relief, asks for a stay pending appeal. the justices are supposed to do what we call balance the equities they re supposed to look at who is harmed more by either letting in this role and go into effect. or keeping it on pause. and so you know the reason why i think this is such a sort of difficult t leave to read is because you could also think that by extending the stay for two more days, the justices are reflected on the point that they don t want because merrick wrong to go into effect at any point. you know, we just don t know at this point. the larger point is that the justice are going to have to say something meaningful on friday because without a state w
Which is what we thought we might get today. the problem with that is that doesn t tell us which side they re on. it doesn t tell us which result that s in support of. it just suggests that whatever ruling we get from the full court on friday, is going to have either or both of some explanation by the majority about why they either are or are not staying. the judge, cosmetics ruling pending appeal and or separate concurrences and dissents, so i think it raises the odds that there will be explanations on friday, but i don t think it really tilts the scales that heavily toward which result will get in. it really is just a play for time on the court s part. jennifer and again, we realized we re asking you guys to read tea leaves here and no one is inside that room right now. but john biskupic made the point. i think you made it as well, jennifer that if they had the votes to issue a more lasting stay here, stay pending appeal that they would have done it not punted. another well, 50 some
Key Takeaways: Two competing federal court preliminary injunction orders were issued April 7, 2023, which have put the continued availability of mifepristone, the primary drug used for.
Physicians from administering the drug and critically, it makes the drug unavailable to women. after seven weeks of pregnancy, the likely result. if this ruling stands well, far fewer women who want to actually be able to use it or senior supreme court analyst job scooping is here with the important new details jonah big ruling last night and had a big decision by the justice department. that s right, john. things are moving so fast, and i think we can expect that over the next 24 36 hours because the original order in this case against the fda approval of the drug was set to take place at the end of friday at midnight, and let me just tell you what attorney general america ireland just put out, he said. the justice department strongly disagrees with the fifth circuit decision. to deny, in part, a request for a stay pending appeal. we will be seeking emergency relief from the supreme court to defend the fda , scientific judgment and protect americans access to safe and effective reprod